101 results
Keyword Blinatumomab Remove keyword
-
List item
European Medicines Agency-EuropaBio information day
European Medicines Agency, London, UK, 22/11/2016, Last updated: 04/11/2016therapies: A case study of blinatumomab versus standard therapy of … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 November 2018
CHMP, Last updated: 16/11/2018blinatumomab) in patients with residual … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 September 2018
CHMP, Last updated: 21/09/2018blinatumomab … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 July 2018
CHMP, Last updated: 27/07/2018of medicine Blincyto INN blinatumomab Marketing-authorisation holder … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 September 2015
CHMP, Last updated: 25/09/2015blinatumomab) for the treatment of Philadelphia … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2020
CHMP, Last updated: 16/10/2020Blincyto INN blinatumomab Marketing-authorisation holder … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 February 2021 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 08/02/2021 to 11/02/2021, Last updated: 08/02/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 25-29 January 2021
Virtual meeting, from 25/01/2021 to 29/01/2021, Last updated: 29/01/2021 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 16/02/2021 -
List item
COMP: Agendas, minutes and meeting reports (updated)
Last updated: 03/02/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 July 2020
European Medicines Agency, Amsterdam, the Netherlands, from 06/07/2020 to 09/07/2020, Last updated: 10/12/2020 -
List item
CHMP: Agendas, minutes and highlights
Last updated: 29/01/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 6-8 October 2020
Virtual meeting, from 06/10/2020 to 08/10/2020, Last updated: 08/10/2020 -
List item
List of medicines under additional monitoring (updated)
Last updated: 24/02/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 9-12 November 2020
Virtual meeting, from 09/11/2020 to 12/11/2020, Last updated: 07/01/2021 -
List item
Recommendations on medication errors
Last updated: 24/06/2020Blincyto, INN-blinatumomab 30 Churchill Place … cancer medicine Blincyto (blinatumomab) is used in a safe and effective …
-
List item
Committee for Medicinal Products for Human Use (CHMP): 12-15 October 2020
Virtual meeting, from 12/10/2020 to 15/10/2020, Last updated: 16/10/2020 -
List item
Medicines under evaluation
Last updated: 16/03/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 28 September-1 October 2020
Virtual meeting, from 28/09/2020 to 01/10/2020, Last updated: 29/09/2020 -
List item
PDCO: Agendas, minutes and meeting reports
Last updated: 11/11/2020 -
List item
Committee for Orphan Medicinal Products (COMP): 1-3 December 2020
Virtual meeting, from 01/12/2020 to 03/12/2020, Last updated: 06/06/2017opinion: • Blincyto (blinatumomab) for treatment of acute lymphoblastic … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 January 2021
Virtual meeting, from 11/01/2021 to 14/01/2021, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 27-30 November 2017
European Medicines Agency, London, UK, from 27/11/2017 to 30/11/2017, Last updated: 27/11/2017 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 July 2017
European Medicines Agency, London, UK, from 03/07/2017 to 06/07/2017, Last updated: 13/03/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 March 2018
European Medicines Agency, London, UK, from 19/03/2018 to 22/03/2018, Last updated: 31/05/2018